SUBSCRIBE
SUBSCRIBE
News   FDA

Pfizer Inc.'s Drug for Nerve Pain, Lyrica Gets Expanded Approval In Japan

October 29, 2010 | 
1 min read
Oct 28 (Reuters) - Japanese health regulators approved Pfizer Inc's (PFE.N) Lyrica to treat a type of nerve pain called peripheral neuropathic pain, Pfizer said on Thursday.
FDA Approvals Asia
Pfizer
MORE ON THIS TOPIC
Illustration of woman checking progress on project
Opinion
FDA Inspections Should Not Be Source of Stress
January 27, 2026
 · 
5 min read
 · 
Greg Walker
Government red tape concept and American bureaucracy symbol as an icon of the flag of the United States with the red stripes getting tangled in confusion as a metaphor for political and administration inefficiency.
Rare diseases
Rare Disease Vouchers Caught in Political Abyss. It Didn’t Have To Be This Way
January 23, 2026
 · 
3 min read
 · 
Heather McKenzie
Business and Project Roadmap Concept. Touching on virtual screen with roadmap overlay representing steps in a project or strategic planning process. Waypoint icons and ends with goal achievement.
Manufacturing
FDA Sets Feb. 1 Launch Date for PreCheck Pilot To Strengthen Domestic Supply Chain
January 22, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Start early or business advantage. Businessman starts running ahead of competitors vector
Pain
Lexicon Opens Path to $1B+ Opportunity as FDA Greenlights Phase III for Non-Opioid Pill
January 22, 2026
 · 
2 min read
 · 
Tristan Manalac